CBX2 and CBX7 are over‐ and underexpressed in a subset of tumor samples; percentage of CBX2 over‐ and CBX7 underexpressing samples increased with breast tumor aggressiveness in both datasets (Fig. 4F). Here, CBX7 is linked to breast neoplasm.